Hi Fattchoi I reckon Imu went with Blincyto because of its efficacy on CD19 and the fact Azcer cell not quite there yet, when trials are approved for Oncarlytics and Azercell combo game over. Blincyto does have some nasty side effects but IMU have tried a few others in preclinical trials and chose them over the others. So we will see but I don’t reckon IMU would talk to anyone just about Oncarlytics without the whole package. Might be wrong but wow if that combination is successful as many hope look out the last CR will be seen as the deal of the millennium.
Ann: Phase 1 onCARlytics Trial Advances to Combination Arm, page-95
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
-0.001(0.93%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.3¢ | $404.0K | 7.432M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 3790463 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 872674 | 14 |
View Market Depth
| Last trade - 12.35pm 30/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |